Agentic BAIM-LLM Evaluation (ABLE): Benchmarking LLM Use of Protein Design Tools

TEXT START: We introduce ABLE, a benchmark for evaluating LLM agents' ability to use biological AI models (BAIMs), such as ProteinMPNN and AlphaFold3, in dual-use protein design workflows.

The Dissection

ABLE measures the point where general-purpose language models become operators of specialized biological systems: retrieving structures, generating sequences, selecting tools, and validating designs. Its decisive finding is not the leaderboard. It is that LLMs already lower the interface cost of protein design, while human expertise is repositioned toward supervision, correction, and exception handling.

The benchmark captures an early automation layer, not autonomous scientific mastery. Seven models refuse all tasks; the others vary sharply in execution. That inconsistency is friction in the pipeline, not evidence that the pipeline cannot scale.

The Core Fallacy

The implicit error is treating present inconsistency as a durable barrier. Planning failures, weak biological integration, and uneven tool use are optimization problems under P1, not permanent protections for human labor. Once specialized BAIMs perform the domain-heavy operations, improving the orchestration layer can progressively strip away the remaining human bottleneck.

The paper also risks equating benchmark competence with safe or meaningful design capability. Tool access plus sequence generation is not the same as reliable biological success. The abstract supports barrier reduction, not proof of fully autonomous protein engineering.

Hidden Assumptions

• That expert humans remain the stable reference point rather than becoming reviewers of increasingly automated workflows.
• That refusal behavior represents a durable safety boundary rather than a policy or model-distribution variable.
• That planning and biological reasoning must remain bundled inside one model instead of being decomposed across agents, BAIMs, validators, and human checkpoints.
• That current performance gaps will persist long enough to preserve a human-only economic domain.
• That measuring capability is separate from accelerating deployment; in practice, a benchmark makes capability legible, comparable, and easier to improve.

Social Function

Classification: partial truth and transition management, with a layer of prestige signaling.

The paper honestly records major weaknesses and refusals, so it is not pure copium. But by converting dual-use capability into a benchmark, it also normalizes the transition from scientist using tools to agent coordinating tools. The leaderboard makes the emerging substitution legible to institutions while the safety framing contains the political shock.

The Verdict

ABLE is an early warning, not a reassurance. It shows that protein design is beginning to detach from exclusive human procedural control. The systems are not yet reliable enough to replace expert judgment outright, but the remaining deficits are visible engineering targets. Under the Discontinuity Thesis, that means the moat is already being surveyed and mapped. Human expertise remains valuable as a temporary verification layer; it is not secure as the permanent engine of productive participation.